Trending Now
Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX) Enters Agreement For Exchange Of Senior Notes...
Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX) has signed a privately-negotiated, separate exchange agreement with specific holders of the 5.25% Convertible Senior Notes that will be due...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
The Bitcoin Bull Rides Again (SQ, OSTK, ISWH, BTBT)
Call it a classic Turnaround Tuesday – traders and investors came storming back into risk assets on Tuesday, driving technology shares, gold,...
MAKE IT MODERN
LATEST REVIEWS
Revance Therapeutics Inc (NASDAQ: RVNC) Is Positioned To Present Its Innovative...
Revance Therapeutics Inc (NASDAQ: RVNC) is ready to make a difference in the prestigious market for aesthetics and therapeutics. With its expertly created products...
MAKE IT MODERN
PERFORMANCE TRAINING
Pasithea Therapeutics Corp (NASDAQ: KTTA) Opens Second Clinic in London For IV Ketamine Therapy...
Pasithea Therapeutics Corp (NASDAQ: KTTA) has announced that its subsidiary, Pasithea Clinics, has opened a second clinical in Marylebone that offers intravenous ketamine therapy...
NVIDIA Corporation (NVDA) could test the lowes again
NVIDIA Corporation (NASDAQ:NVDA)stock has already dropped 50% from its highs and looks like it could still retest the lows this week.
The stock just saw...
Allogene Therapeutics Inc. (NASDAQ: ALLO) and Antion Biosciences announce Exclusive Global Partnership Agreement for...
Allogene Therapeutics Inc. (NASDAQ: ALLO) and Swiss cell and gene engineering firm Antion Biosciences have announced the signing of an exclusive partnership and global...
Nurix Therapeutics Inc. (NASDAQ: NRIX) Announce Preliminary Findings Showing BTK inhibitor Degradation in r/r...
Nurix Therapeutics Inc. (NASDAQ: NRIX) has announced preliminary data showing clinically significant Bruton's tyrosine kinase inhibitor degradation in patients with refractory or relapsed B...
Moderna (NASDAQ: MRNA) Receives Emergency Use Authorization For Its COVID-19 Vaccine In Adolescents in...
Moderna (NASDAQ: MRNA) has received approval from the Philippines Food and Drug Administration for its coronavirus vaccine for children between 12 and 17 years.
The...
MAKE IT MODERN
